Related by context. All words. (Click for frequent words.) 66 DIAGNOSTIC 65 FAVOURED 65 DRIVEN TO 64 ACCORDINGLY 64 PSYCHOLOGICAL 64 UNFIT FOR 64 STILL NEED 64 HAND TO 64 CAUSES OF 64 DEGREE OF 64 OFF YOUR 64 TREATMENTS 63 DISPLAY OF 63 ON GETTING 63 OBSERVED 63 BEWARE THE 63 THE LEAST 63 STUFF THAT 63 THE EVIDENCE 63 VERDICT ON 63 DIAGNOSIS 63 IN DOUBT 63 PLEASE BE 63 WASHED 63 THEY CAN NOT 63 TREATMENT FOR 63 UPSETTING 63 CLEANS UP 63 MAY NEED 63 TRAINING FOR 62 DOWNWARD 62 WHO NEEDS 62 REGAIN 62 PATIENTS WHO 62 KNEE SURGERY 62 SCANS 62 RUNNING OUT OF 62 ABSENCE 62 SENSE OF 62 TEST OF 62 HIGH GRADE 62 BAD FOR 62 ALTERED 62 MESSAGE FROM 62 STRESS AND 62 ELUSIVE 62 FAIR TRIAL 61 TREATMENT OF 61 HARD TO 61 GOODBYE TO 61 HIS FACE 61 CLEAR OUT 61 PATTERN 61 SHARPER 61 EVIDENCE THAT 61 TO RECOVERY 61 LIGHTLY 61 ADJUSTING TO 61 VICTORY FOR 61 IMPOSSIBLE TO 61 WINDOW OF 61 COMIN 61 HOW THEY 61 DUE FOR 61 BARBARO 61 CLINICAL TRIAL 61 DEFINING 61 NOT TAKING 61 PONDERING 61 SUGGEST THAT 61 BATTLING FOR 61 FOCUSING ON 61 APPROACH TO 61 NOT GETTING 61 THEIR ACTIONS 61 PROCEDURE 61 LESSONS FROM 60 RESPOND TO 60 VIRTUE 60 QUESTIONS ABOUT 60 STINGS 60 FAMILY MEMBER 60 FAILED TO 60 BEHAVIORAL 60 MAY CHANGE 60 GONE FOR 60 COMMENTS ON THE 60 WHY THEY 60 TOTALLY DIFFERENT 60 GIVE HIM 60 FRIGHTENING 60 MOVEMENTS 60 WEINBERG 60 IN PATIENTS WITH 60 INTENTIONS 60 EXPERIMENT 60 OPERATIVE 60 BREEZY 60 HEADACHE 60 THAT WAS NOT 60 DIFFERING 60 INTENSITY 60 IMPERFECT 60 ONE FOOT 60 DO NOT LEAVE 60 REVISE 60 HAVE AN 60 ENOUGH OF 60 DEPEND ON 60 GENES 60 GAME IS 59 APPEALING 59 IMPRESSION 59 CALL HIM 59 NOT GOING 59 START WITH 59 LEINART 59 FAKED 59 WORDS OF 59 ADDRESS BY 59 RADICALS 59 CLEARER 59 SOCIEDAD 59 KNOW YOUR 59 COMPLETING THE 59 INSPECT 59 PARTNER WITH 59 RLY 59 REFRESHING 59 PHRASE 59 EXAMPLES OF 59 THE SUBJECT 59 CAN NOT WIN 59 DRAWS 59 BEARER 59 SETBACKS 59 MATTER OF 59 EXCHANGE OFFER 59 ADVISED 59 IS WRONG 59 FOLLOW UP ON 59 BLOOD TEST 59 OF LAW 59 'S DAY 59 'S TRIAL 59 TRACK RECORD 59 SPARES 59 STILL POSSIBLE 59 RISKY 59 CROCK 59 JUST BE 59 AND YET 59 CEILING 59 BACK PAIN 59 TRIED AND 59 BRAWN 59 PROSPECTOR 59 INSURANCE INDUSTRY 58 TREATMENT 58 TO VOTE FOR 58 PICKED TO 58 IS VERY 58 SPICE UP 58 EXTENDING THE 58 DEFINED 58 WAIT UNTIL 58 CUTTING THE 58 FORGET THE 58 WAY TO THE 58 PROCEDURES 58 SOMEWHAT 58 HILLARY 'S 58 DIFFER 58 CONCISE 58 CRY FOR 58 GIVING UP 58 SHOCKEY 58 PAGING 58 PULMONARY 58 CUT DOWN 58 PANEL ON 58 TYPES OF 58 'S WELL 58 GOOD HEALTH 58 DETECTION 58 ACCEPT THE 58 OUR LOCAL 58 EXPECTATION 58 PUSHING THE 58 LAPSE 58 FUNCTIONING 58 CONDITIONAL 58 AND RUN 58 TESTER 58 SENSING 58 CONUNDRUM 58 VARY 58 PEDIATRIC 58 NO ROOM 58 TIMELY 58 UNNECESSARY 58 MESSAGE TO 58 IMPROPERLY 58 WE DO NOT NEED 58 ADVISES 58 PATIENCE IS 58 REASONS FOR 58 'S GONE 58 BUSTS 58 TO CONGRESS 58 APPROXIMATE 58 THE WHOLE STORY 58 HURDLE 58 SPEECHES 58 SLOW TO 58 COMPARING 58 PARKINSON 'S DISEASE 57 HYPERTENSION 57 CONNECTION BETWEEN 57 APPARENT 57 FORGIVENESS 57 TUMORS 57 SENSITIVITY 57 MORTALITY 57 INTEREST OF 57 USE YOUR 57 CAN NEVER 57 GREEN LIGHT 57 CAUTIONS 57 GOVERN 57 FAVORABLE 57 NO SHOWS 57 NEW AGE 57 VIABLE 57 VIOLATIONS OF 57 ASSESSING 57 ON ARRIVAL 57 FLEETING 57 THE WAY FORWARD 57 SIZE AND 57 SUGGESTED 57 STATIONARY 57 TRADITION OF 57 LACKING 57 BEING TAKEN 57 SUCCESSES 57 YOU HAVE TO BE 57 EXCUSES 57 LIMB 57 SERENE 57 TO REMEMBER 57 ANSWER TO 57 THE BUBBLE 57 PROFILING 57 FLAWED 57 SALUTING 57 INVESTIGATION OF 57 HEART FAILURE 57 HEADLIGHTS 57 DEFINES 57 REALLY GOOD 57 ENTRANCE 57 PRESIDING 57 DISCOMFORT 57 EVALUATION OF 57 LOCKER 57 REDUCES 57 FAILURE TO 57 HEARING ON 57 RECOMMENDED 57 SUGGEST 57 TRIGGER 57 AMISH 57 QUEST FOR 57 BEAT THE 57 CONSENT 57 HARD TO GET 57 DELIBERATIONS 57 CONFIRM 57 TOP SEEDS 56 EVALUATE 56 INDICATIONS 56 MYTHICAL 56 ASSESSMENTS 56 INDICATION 56 PART TWO 56 PETITION TO 56 WE DO NOT WANT 56 INEVITABLE 56 OUTCOMES 56 RETHINK 56 FREE AGENT 56 NEED AN 56 MINIMIZE 56 HIM UP 56 CLEARING THE 56 TARGET OF 56 NO GO 56 ON THE SAME 56 TEST RESULTS 56 REQUEST FOR 56 IMPLEMENT 56 UNREASONABLE 56 MICHIGAN 'S 56 EXPLAINING 56 IS NEEDED 56 DO NOT COUNT 56 FAINT 56 BRUIN 56 FORTUNATE 56 IN NEW HAMPSHIRE 56 CASE AGAINST 56 SMALL BUSINESS SET ASIDE 56 'S COMMENTS 56 BACK DOOR 56 FAILURES 56 WARNING SIGNS 56 CHOOSE YOUR 56 SENSITIVE 56 INITIAL 56 NOT MISS 56 DRUG COMPANIES 56 SAMPLING 56 PHILOSOPHICAL 56 EMISSION 56 WAITING FOR THE 56 FATTY 56 OUR CONSTITUTION 56 RELATES TO 56 FOR HOW LONG 56 DID NOT WANT 56 PERV 56 LACK OF 56 LAST TWO YEARS 56 ORGANISE 56 THE DESTRUCTION OF 56 CRITICAL 56 FOR CHANGE 56 CONSISTENT 56 BENEFICIAL 56 UNDERSTANDING THE 55 PARAMETERS 55 TERMINATE 55 FUNCTIONAL 55 SELECTIVE 55 IMPLICATIONS 55 MARGIN OF 55 DISCLOSED 55 FLICK 55 AN EARLIER 55 NOSE 55 LOOKING OUT 55 TIMETABLE FOR 55 SEEING THE 55 SERVICING 55 ODDS OF 55 MALES 55 DO NOT GO 55 ACKNOWLEDGE 55 DEFINITE 55 PRUDENT 55 RENAL 55 APPROVALS 55 PROJECTIONS 55 HEARINGS 55 NO ORDINARY 55 MEMO TO 55 DEMONSTRATE 55 DISGRACEFUL 55 PREVAIL 55 ENVELOPE 55 MOCK 55 ADVISER 55 REPUBLICANS AND 55 INFLUENCE 55 EXPIRE 55 INEFFECTIVE 55 BREEDS 55 CLAUSES 55 SYMPTOMS 55 IS SUSPENDED 55 SURVIVE 55 FOR AMERICA 55 THE FUNNIEST 55 INDUCED 55 DEAR FEELING 55 CRAPPY 55 HALTS 55 GASTRIC 55 OMITTED 55 MARGINAL 55 KING JAMES 55 RECOMMEND 55 SILVER BULLET 55 SUMMONS 55 ASSAYS 55 THE PROCESS 55 UNTIL FURTHER NOTICE 55 E1 CLO 55 VAN DE VELDE 55 HABITS 55 BETTER BE 54 KNOW WHEN 54 SECOND AMENDMENT 54 INCLUSIVE 54 HAPPENING 54 WHATS 54 DIFFERENCES 54 WILL BE NOTIFIED 54 MIXED UP 54 IS WELL 54 REALISTIC 54 EXPLANATION 54 QUANDARY 54 LEFT TURN 54 HORIZONS 54 HEALTH CARE BILL 54 NARROW 54 COMMITTEE CHAIRMAN 54 SUCCESSION 54 INCOMPLETE 54 ASSUMPTIONS 54 HINTS 54 BETTER FUTURE 54 TRIAL COUNSEL 54 PILOT PROGRAM 54 SECOND TERM 54 IMPROVE 54 EVALUATION 54 'S STATEMENT 54 IGNORANCE IS 54 NATURE AND 54 IMPORTANCE 54 MID TERM 54 IT TURNS OUT 54 WALK THROUGH 54 ENTITLEMENTS 54 NORMS 54 YOURSELVES 54 URGENCY 54 CONVENIENT 54 THE MADNESS 54 SCROLL 54 NOVELTY 54 RELATED COMPANIES 54 RELEVANCE 54 PASSIVE 54 YOU DO NOT NEED 54 MISLEADING 54 PROSPECTS FOR 54 CONVERT 54 PRIMARIES 53 IS EVERYTHING 53 WATCHER 53 RENEWAL OF 53 SOME MONEY 53 ESTABLISH 53 INDIRECT 53 IGNORED 53 DEMOCRATIC PRESIDENTIAL 53 SUPPORT STAFF 53 NO CHANGES 53 CONSENSUS 53 REPOST 53 ACCELERATION 53 LAYING THE 53 SUMMARY OF THE 53 PRESIDENT 'S 53 PATENTS 53 DEVELOPMENTS 53 SELIG 53 HOLD THAT 53 TOLERATE 53 ACCURACY 53 ROAD MAP 53 RECOMMENDATIONS 53 ASK THE 53 NOD FOR 53 FOR PUBLICATION 53 NOT MAKING 53 LAURA 'S 53 REASONING 53 OUR FUTURE 53 GEST 53 WAIVE 53 PAYING ATTENTION 53 BACKGROUND AND 53 DO NOT PLAY 53 COMMON SENSE 53 BIASED 53 POLITICAL PARTY 53 BRANGELINA 53 SEPARATION 53 MCCAIN 'S 53 LONGEST 53 CONSEQUENCE 53 METALLURGICAL 53 BOLDIN 53 ASST 53 DEEPER 53 COMPRESSION 53 TRUST AND 53 DIVERSIFY 53 ON THEIR OWN 52 TO AVOID PREGNANCY WHILE 52 FOLLOW THROUGH 52 ENHANCEMENT 52 ALLOW ME 52 FIRST CAREER 52 ALL SIDES 52 SIMILAR 52 WHAT IS RIGHT 52 LITTLE HELP 52 DISTINCT 52 'S APPEAL 52 PUBLIC MONEY 52 FAULT 52 ASSIGNMENT OF ERROR 52 RAMP UP 52 MY OPINION 52 RECOVER 52 GO GET 52 TRAFFIC SAFETY 52 BUDGETING 52 SPOKESPERSON 52 OPPOSES 52 RESPONDS 52 ARTICLES 52 ASSESSMENT 52 JEET DA 52 VERY SMALL 52 HEALTH PLAN 52 SUMMARY JUDGMENT 52 CARRYING THE 52 CIVIL SUIT 52 AND RECOMMENDATIONS 52 FOR RELEASE 52 ACCESSION 52 INEPT 52 CONTINUITY 52 SPINE 52 SIGNAL 52 MASS TRANSIT 52 Patients Undergoing 52 RECOGNIZING 52 BINDING 52 EXISTS 52 Implantable Defibrillator 52 TAX PLANNING 52 GORD 52 WARNINGS AND 52 COMMISH 52 MCNABB 52 DEPENDENCE 52 PARTISAN 52 JUDICIAL 52 ADVANTAGES 52 ENSURE 51 GUARANTOR 51 HOW TO DEAL WITH 51 NO SUCH THING 51 UNSOLICITED 51 GRANT PROGRAM 51 OBSERVATION 51 MOST IMPORTANT 51 PAROLE BOARD 51 USAGE 51 BALANCED 51 MUST DO 51 PROPERTY FUND 51 DEFINITIVE 51 INCORRECT 51 ELECTION DAY 51 BIPARTISAN 51 ALIGNMENT 51 DETERMINATION 51 NO MORE EXCUSES 51 PIXEL 51 HOMELAND SECURITY 51 HEALTH REFORM 51 CONTRAST 51 APPRAISAL 51 FUNCTION 51 RICHTER 51 THIS LAND 51 PARTICIPATION 51 ABSTRACTS 51 BUMBLE 51 OPTION 50 CLASS ACTION 50 QUERY 50 FUNDAMENTALS 50 COMPREHENSIVE PLAN 50 DEPENDENT 50 EXTENT OF 50 BARNARD 50 DEFER 50 Acute Ischemic Stroke 50 FINDINGS 50 HEREBY 50 EXECUTION 50 TROUGH 50 THE TREASURY 50 Stent Implantation 50 BIDDER 'S 50 VERY IMPORTANT 50 IN THIS WEEK 50 MORE EFFECTIVE 50 CONSIDERATION 50 ACCEPTANCE 50 MEDIATE 50 THIS NOTICE IS 50 OBJECTIVES 50 ENTITY 50 NOTHING WRONG 50 Acute Coronary 50 IGNORANCE 50 STRATEGIC PLAN 50 FAVORED 50 APPROVE 50 CLEAN WATER 50 DOCTRINE 50 Chemoradiation 50 SHRINK 50 UNLOAD 50 ADDITION 50 TRUS 50 REVERSAL 50 AUDIT 50 ATTRACT 49 SELECTMEN 49 gadolinium enhanced 49 RATIONALE 49 CLUB LUNCHEON 49 TAX CUT 49 REPORT CARD 49 ABSTRACT 49 AND ANALYSIS 49 DIRE 49 FEMALES SHOULD BE ADVISED 49 COINCIDENCE 49 PRINCIPLE 49 EISNER 49 SUBMISSIONS 49 THE CAPITOL 49 Prospective Randomized 49 LIKELIHOOD 49 REQUEST FOR PROPOSALS 49 Mitral Regurgitation 49 Patency 49 FOSSIL FUELS 49 PRIORITY 49 PETROLEUM LIMITED 49 PARR 49 Elderly Patients 49 Ultrasonography 49 LEFTOVER 49 MANAGING DIRECTOR 49 METHODS 49 RESOLUTIONS 49 FLAIR 48 REALISM 48 ALITO 48 RESOLUTION NO 48 CRITERIA 48 NORBERT 48 PARAGRAPH 48 TRUTHS 48 PROCEED 48 REFUSAL 48 STURM 48 COUNSEL FOR 48 Metastatic Prostate Cancer 48 ASSISTED SUICIDE 48 TRANSFORMS 48 PURPOSE 48 HOME LOANS 48 Drug Eluting Stents 48 CIVIL RIGHTS 48 PLAINTIFFS 48 PRE APPROVED 48 PENSION FUND 48 Acute Myocardial Infarction 48 HOPED 48 FACTOR 48 VALUATION 48 ACCOMPLISH 48 OFFICIATING 48 COUNSEL 48 Improves Outcomes 48 Ischemic Stroke 48 TOLERANCE 48 AND SHOOT 48 TRICKLE DOWN 48 CONSIDERATIONS 48 Pelvic Organ Prolapse 48 bone scintigraphy 48 Venous Thrombosis 48 DISCONNECT 48 LEGITIMATE 47 II Clinical Trial 47 THERE IS AN 47 Improves Survival 47 Adjuvant Chemotherapy 47 DIVERSIFICATION 47 TREND 47 STEFFEN 47 Left Ventricular 47 ADOPTION OF THE 47 Prospective Randomized Trial 47 RESPONSES 47 DEFINITION 47 CONCLUSION 47 Duodenal 47 GOODELL 47 HORIZONTAL 47 DELEGATE 47 NO PROGRESS 47 ENDORSE 47 LAMICTAL 47 STICH 47 Cardiovascular Events 47 FOLLOW UP 47 renal artery stenosis 47 PROVE IT 47 Bone Mineral Density 47 ASKED OF 46 STEINBECK 46 'S RESPONSE 46 Ventricular Tachycardia 46 TAX RATES 46 GOUT 46 HASTE 46 CRYSTAL 46 YOUR GOALS 46 ACTIONS 46 FDG-PET/CT 46 REDUX 46 Resynchronization 46 PATAKI 46 AMENDMENT 46 Cardiogenic Shock 46 Matoaca Magisterial District 46 Prospective Multicenter 46 NOT AVAILABLE 46 RATIO 46 REPLY 46 TRAIL 46 Percutaneous Coronary Intervention 46 Adjuvant Therapy 46 BLACKED OUT 45 GOVERNANCE 45 FIELD 45 PROWESS 45 Recurrence 45 CHANDRA 45 CHANT 45 MR Angiography 45 LOAD 45 FAVOR 45 SPECIAL EVENTS 45 Metabolic Efficiency 45 Treatment Regimens 45 6 mercaptopurine 45 Carotid Stenting 45 ACCLAIM 45 Phase 2b Study 45 MISMANAGEMENT 45 Infarction 45 Randomized Controlled Trial 45 Thrombolysis 45 Demonstrates Significant 45 CHANCES OF SEEING 44 SUBJ 44 Meta Analysis 44 Reperfusion 44 REALITY CHECK 44 Statistically Significant 44 REBUTTAL 44 TAPAS 44 Predictive Value 44 Carotid 44 immunohistochemical analysis 44 OBJECTIVE 44 PRESERVE 44 FELDMAN 44 MIKE PENCE R 44 NEW POLL 44 OPPOSE 44 Subgroup Analysis 44 Liver Failure 44 Novel Technique 44 Atrial 44 Stable Angina 44 BLIP 44 Abnormality 44 Radical Prostatectomy 44 PROACTIVE 44 REGARD 44 LITT 44 CORNERS 44 Relapsing Multiple Sclerosis 44 #F FDG PET 44 Localized Prostate Cancer 43 substudy 43 DEAR 43 Is Well Tolerated 43 Stent Restenosis 43 Inhaled Corticosteroids 43 PHILPOTT 43 OF STEFFANIE RIVERS 43 FLANDERS 43 Dual Antiplatelet Therapy 43 Abciximab 43 NOWHERE 43 Unresectable 43 Patients Treated 43 Aortic Valve 43 preoperative diagnosis 43 Newly Diagnosed Multiple Myeloma 43 YOU DECIDE 43 Clinical Outcome 43 CARR 43 Asymptomatic 43 PROSPECT 43 Intracerebral Hemorrhage 43 Clinical Relevance 43 Randomized Controlled Trials 43 Monotherapy 43 Controlled Trial 43 Relapsing Remitting Multiple Sclerosis 42 perfusion imaging 42 mucinous 42 POISE 42 Antitumor Activity 42 Contralateral 42 Obese Patients 42 LIEBERMAN 42 Myeloid 42 polyposis 42 RE ENTRY 42 Appears Safe 42 Prevent Stroke 42 Improve Survival 42 MARAIS 42 Disease Progression 42 RANK 42 bladder dysfunction 42 Low Density Lipoprotein Cholesterol 42 LIFTING THE 42 Statin Therapy 42 Prostatectomy 42 Tolerability 42 Randomized Placebo Controlled Trial 42 OTHER ISSUES 41 Echocardiographic 41 Survival Benefit 41 MONIES 41 Idiopathic 41 ROTHENBERG 41 Castration Resistant Prostate Cancer 41 adjuvant radiotherapy 41 NO VOTE 41 echocardiographic 41 Pegylated Liposomal Doxorubicin 41 Sirolimus Eluting Stent 41 Antiviral Activity 41 Histologic 41 GOOD GOVERNANCE 41 scintigraphic 41 Coronary Artery Bypass Surgery 41 Radiofrequency Ablation 41 Ventricular 41 CONT 41 extracranial 41 Resection 41 Long Term Outcomes 41 Prognostic Value 41 Induction Therapy 41 VALUE 41 endoscopic ultrasonography 40 CONCLUSIONS 40 Intracranial 40 carotid revascularization 40 Receptor Antagonists 40 Hemolysis 40 neurologic deficits 40 osteochondroma 40 papillary thyroid carcinoma 40 HRCT 40 prognostic factor 40 pathologic diagnosis 40 Hepatic Impairment 40 ultrasonography 40 Stenting 40 Metastatic Renal Cell Carcinoma 40 Pharmacokinetic Study 39 Ranolazine 39 neoadjuvant 39 urothelial carcinoma 39 paragangliomas 39 diffusion weighted 39 Clinical Efficacy 39 bosentan 39 Postoperative 39 sonographic findings 39 Estrogen Receptor 39 reflux esophagitis 39 RECENT EVENTS 39 functional mitral regurgitation 39 perioperative complications 39 pseudoaneurysm 38 SRINIVASAN 38 Intervention Trial 38 TOP2A 38 Rheumatoid Arthritis Patients 38 Non Responders 38 HGPIN 38 hyperintensity 38 intraventricular 38 Neoadjuvant Chemotherapy 38 Subcutaneous 38 Fasting Glucose 38 lymphadenectomy 38 Neuroprotective Effects 38 atherosclerotic renal artery stenosis 38 MR angiography 38 restenotic lesions 38 Randomized Evaluation 38 Sipuleucel T 38 ventricular myocardium 37 Dexamethasone 37 immunoreactive 37 postoperative radiotherapy 37 Dyspnea 37 BRODER 37 FDG uptake 37 liver metastasis 37 Coronary Syndromes 37 Radiation Dose 37 nodal metastases 37 Double Blind Randomized 37 Significant Efficacy 36 tirofiban 36 pneumonectomy 36 Clinical Trial Data 36 Improve Outcomes 36 FDG PET 36 chemoradiotherapy 36 CHMP Opinion 36 FEINGOLD 36 Partial Seizures 36 adrenalectomy 35 Immunosuppression 35 mediastinal 35 nonoperative treatment 35 Intraperitoneal 35 cystectomy 35 RECOMMENDATION 35 Pharmacokinetic 35 ventricular dysfunction 35 Data Suggest 35 Kaplan Meier analysis 35 LV ejection fraction 35 PROBABILITY 34 Occurs 34 Potent Inhibitor 34 LV hypertrophy 34 Dissociation 34 locoregional 34 multivariable analysis 33 QTc 33 parenchymal 33 dyssynchrony 33 prognostic significance 33 ipsilateral 33 PEEP 33 MDRD 33 neoadjuvant chemotherapy 32 nephron sparing surgery 32 rCBF 32 thalamic 32 subgroup analyzes 32 Meet Primary Endpoint 31 cerebral perfusion 31 immunoreactivity 31 left ventricular LV 30 periprocedural 30 Conclusion 30 Main Outcome Measures 30 CR CRu 29 Predictors 29 BALF 28 extensive metabolizers 28 Conclusions 28 cells transfected 26 #,#-# [012] 24 Feasible 22 DHCA